Day Gain | ||
Gain | ||
Market Val | ||
Costs | ||
Cash | ||
Portfolio | ||
Realized | ||
Dividend |
Eli Lilly and Company (NYSE:LLY) Trading Down 0.1% | news.google.com • |
Earnings Exchange: McDonald's, Brinker International, Eli Lilly | youtube.com • |
Markets Up on Tesla, Q1 Earnings; Q1 Beats After the Bell | zacks.com • |
How To Earn $500 A Month From Eli Lilly Stock Ahead Of Q1 Earnings Report | news.google.com • |
Here's How Much Stock Eli Lilly Repurchased in 2023 | news.google.com • |
Here's How Much Stock Eli Lilly Repurchased in 2023 | news.google.com • |
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-04-30 | 2024-03 | 2.53 | N/A | N/A | N/A |
2024-02-06 | 2023-12 | 2.47 | 2.49 | 0.02 | 0.81% |
2023-11-02 | 2023-09 | -0.08 | 0.1 | 0.18 | 225.00% |
2023-08-08 | 2023-06 | 1.98 | 2.11 | 0.13 | 6.57% |
2023-04-27 | 2023-03 | 1.73 | 1.62 | -0.11 | -6.36% |
2023-02-02 | 2022-12 | 1.83 | 2.09 | 0.26 | 14.21% |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-10-10 | Morgan Stanley | Upgrade | Overweight | Overweight |
2023-10-08 | Wells Fargo | Upgrade | Overweight | Overweight |
2023-10-08 | Cantor Fitzgerald | Upgrade | Overweight | Overweight |
2023-10-01 | Cantor Fitzgerald | Upgrade | Overweight | Overweight |
2023-09-04 | Cantor Fitzgerald | Upgrade | Overweight | Overweight |
2023-09-04 | Morgan Stanley | Upgrade | Overweight | Overweight |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2024-04-14 | ALVAREZ RALPH | Director | 54.03K | Stock Award(Grant) |
2024-02-11 | HAKIM ANAT | General Counsel | 30.48K | Stock Award(Grant) |
2024-04-14 | HEDLEY MARY LYNNE | Director | 1.58K | Stock Award(Grant) |
2024-04-14 | JOHNSON KIMBERLY H | Director | 2.63K | Stock Award(Grant) |
2024-02-15 | LILLY ENDOWMENT, INC. | Beneficial Owner of more than 10% of a Class of Security | 98.90M | Sale |
2024-04-14 | LUCIANO JUAN R | Director | 15.68K | Stock Award(Grant) |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-09-29 | Lilly Endowment, Inc | 99.98M | 53.70B | 10.53% |
2023-06-29 | Vanguard Group Inc | 69.92M | 32.79B | 7.37% |
2023-06-29 | Blackrock Inc. | 64.45M | 30.23B | 6.79% |
2023-06-29 | PNC Financial Services Group, Inc. | 51.87M | 24.33B | 5.46% |
2023-06-29 | State Street Corporation | 33.88M | 15.89B | 3.57% |
2023-06-29 | FMR, LLC | 32.80M | 15.38B | 3.46% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 26.65M | 12.50B | 2.81% |
2023-06-29 | Vanguard 500 Index Fund | 18.76M | 8.80B | 1.98% |
2023-06-29 | Vanguard/Primecap Fund | 13.35M | 6.26B | 1.41% |
2023-05-30 | Fidelity 500 Index Fund | 8.83M | 3.79B | 0.93% |
2023-08-30 | SPDR S&P 500 ETF Trust | 8.68M | 4.81B | 0.91% |
2023-08-30 | iShares Core S&P 500 ETF | 7.37M | 4.08B | 0.78% |
Dividend | Date |
---|---|
1.3 | 2024-02-15 |
1.3 | 2024-02-14 |
1.13 | 2023-11-14 |
1.13 | 2023-09-08 |
1.13 | 2023-08-14 |
1.13 | 2023-05-12 |
Split | Date |
---|---|
2 : 1 | 1997-10-16 |
2 : 1 | 1995-12-21 |
2 : 1 | 1989-05-01 |
2 : 1 | 1986-01-30 |
-
“makes no sense”
youre right, it doesnt
-
JPMorgan reiterates Eli Lilly as overweight
JPMorgan said it’s bullish heading into earnings on April 30.
“More broadly on the story, LLY remains one of our favorite names in the group as we see further upside to Street estimates as Mounjaro continues to ramp and Zepbound fully launches as well as a number of additional incretin datapoints
-
Opportunity knocking
-
$LLY My Nephew works here and I ask all the time for details and he only says “buy all you can uncle
-
$LLY My Nephew works here and I ask all the time for details and he only says “buy all you can uncle
-
$LLY My Nephew works here and I ask all the time for details and he only says “buy all you can uncle”
-
$LLY Best of Breed Bitches. Viking is phase 2 years away. We are King in 5 categories. Going much higher soon.
-
$LLY Numerous Approvals Any Day Now
-
$LLY Best of Breed in Numerous Groundbreaking Areas! Alzheimers, Weight Loss, Diabetes, Liver Disease, Heart. Best!
-
$LLY Best Of Breed in 5 Major Categories
-
$LLY You have to be an Idiot to short he with Numerous Pending FDA Approvals in Life Changing Drugs. Weight Loss, Diabetes, Fatty Liver, Alzheimer’s and more. $1,700 in a year….
-
Looks like someone just bought 100K of $LLY 🤩
Nancy is that you?! -
$LLY Oversold here. Buying with both hands!
-
$LLY Only a Fool would be selling here. This stock will be $1,500+ in a year….
-
-
$LLY Shorts will be destroyed when numerous drug approvals come through soon….
-
$LLY Novo in stage 1. Years off. Lilly Best of Breed
-
$LLY , NVO Is in stage 1. Years away. Oversold
-
Eli Lilly and Company (NYSE:LLY) Trading Down 0.1%
news.google.com • -
Here's How Much Stock Eli Lilly Repurchased in 2023
news.google.com • -
Here's How Much Stock Eli Lilly Repurchased in 2023
news.google.com • -
LLY and GOOG look great as the stock market tries to recover
news.google.com • -
PFE vs. LLY: Which Stock Should Value Investors Buy Now?
news.google.com • -
Eli Lilly and Company (NYSE:LLY) Shares Up 1.5%
news.google.com • -
How To Trade (LLY)
news.google.com • -
Eli Lilly (NYSE:LLY) Notches Up on New Manufacturing Plans
news.google.com • -
Eli Lilly and Company (NYSE:LLY) Stock Price Up 1.5%
news.google.com • -
What You Need To Know Ahead of Eli Lilly's Earnings Report Tuesday
investopedia.com • -
Stock Quote & Chart | Eli Lilly and Company
news.google.com • -
A 3x Expected Rise In Mounjaro Sales Is Likely To Drive Eli Lilly's Q1
news.google.com • -
Eli Lilly and Company (NYSE:LLY) Stock Price Down 1.3%
news.google.com • -
Is Eli Lilly Stock A Buy After Weight-Loss Win In Sleep Apnea?
news.google.com • -
Don't Miss Out! 3 Top-Tier Blue-Chip Growth Stocks for Your Must-Buy List
investorplace.com • -
Eli Lilly & Company (LLY) Should Continue Bullish Rally
news.google.com • -
LLY vs. JNJ: Which Big Pharma Stock Is Better?- TipRanks
news.google.com • -
Which Companies Will Join the Trillion-Dollar Team in 2024? Our 3 Best Guesses
investorplace.com • -
Should Eli Lilly (LLY) Be in Your Portfolio Ahead of Q1 Earnings?
news.google.com • -
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
news.google.com • -
Eli Lilly (LLY) Reports Next Week: Wall Street Expects Earnings Growth
news.google.com • -
Eli Lilly (LLY) Reports Next Week: Wall Street Expects Earnings Growth
news.google.com • -
Eli Lilly (LLY) Reports Next Week: Wall Street Expects Earnings Growth
news.google.com • -
Eli Lilly and Company (LLY) to Release Quarterly Earnings on Tuesday
news.google.com • -
7 High-Flying Stocks That Are Majorly Overdue for a Pullback
investorplace.com • -
Wegovy vs. Zepbound: Who Wins the Battle of the GLP-1 Drugs?
marketbeat.com • -
Bearish on SMCI & Bullish on LLY, NFLX
youtube.com • -
Strong Buy Alert: 7 No-Brainer Stocks to Scoop Up Now
investorplace.com • -
Big pharma: cautious optimism ahead of earnings season - analysts
proactiveinvestors.com • -
Eli Lilly's Chart Gets Another Boost from Obesity Drug
youtube.com • -
Eli Lilly's Weight-Loss Treatment Found To Help Those With Sleep Apnea
investopedia.com • -
Eli Lilly's weight-loss drug Zepbound might help cure your sleep apnea
fastcompany.com • -
Eli Lilly Stock Pops on Drug Efficacy for Sleep Apnea
schaeffersresearch.com • -
Eli Lilly's weightloss drug helps reduce sleep apnoea
proactiveinvestors.com • -
Shed the Fat, Gain the Profits: 3 Weight-Loss Stocks to Own Until 2027
investorplace.com • -
3 Growth Stocks with Even Greater Potential Than the Magnificent 7
investorplace.com • -
Why Eli Lilly Stock Topped the Market Today
fool.com • -
The 3 Best Healthcare Stocks to Buy in April 2024
investorplace.com • -
Biotech's Next Gold Rush: Weight-Loss Drugs
youtube.com •